Department of Urology, Jichi Medical University, Tochigi, Japan.
Department of Urology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
Asian J Endosc Surg. 2022 Apr;15(2):255-260. doi: 10.1111/ases.12989. Epub 2021 Oct 3.
To clarify the safety and efficacy of en bloc simultaneous robot-assisted radical cystectomy (RARC) and laparoscopic nephroureterectomy (LNU) for synchronous muscle-invasive bladder carcinoma and upper tract urothelial carcinoma (UTUC) or UTUC of a solitary kidney, we evaluated the perioperative and short-term outcomes of this surgical procedure compared with those of simultaneous open radical cystectomy and nephroureterectomy.
We prospectively enrolled consecutive patients receiving en bloc simultaneous RARC and LNU between December 2018 and March 2020 at two institutes. Patients' characteristics, surgical, perioperative, and pathological outcomes and recurrence rate within 6 months were compared with a historical control receiving simultaneous open radical cystectomy and nephroureterectomy.
Ten patients receiving simultaneous RARC and LNU and 17 receiving simultaneous open radical cystectomy and nephroureterectomy were included in the study. Simultaneous RARC and LNU significantly reduced bleeding volume and blood transfusion (P < .0001, P < .0001, respectively) and significantly prolonged operating time (P = .035). RARC and LNU significantly shortened hospitalization after operation (P = .003) and showed reduced tendency of postoperative complications within 30 days but not significantly (P = .25). Pathological characteristics and recurrence within 6 months were not significantly different between the two groups.
Our results suggested that en bloc simultaneous RARC and LNU were safer surgical procedures with equivalent short-term oncological outcomes compared to conventional open procedures. It can be a standard minimally invasive surgical method in countries where robot-assisted radical nephroureterectomy is inaccessible.
为了阐明整块同期机器人辅助根治性膀胱切除术(RARC)和腹腔镜肾输尿管切除术(LNU)治疗同步肌层浸润性膀胱癌和上尿路尿路上皮癌(UTUC)或孤立肾 UTUC 的安全性和有效性,我们评估了与同期开放性根治性膀胱切除术和肾输尿管切除术相比,这种手术的围手术期和短期结果。
我们前瞻性地招募了 2018 年 12 月至 2020 年 3 月在两个机构接受整块同期 RARC 和 LNU 的连续患者。比较了患者的特征、手术、围手术期和病理结果以及 6 个月内的复发率,并与同期接受开放性根治性膀胱切除术和肾输尿管切除术的历史对照进行了比较。
10 例接受同期 RARC 和 LNU 治疗,17 例接受同期开放性根治性膀胱切除术和肾输尿管切除术的患者纳入本研究。同期 RARC 和 LNU 显著减少了出血量和输血(P <.0001,P <.0001),并显著延长了手术时间(P =.035)。RARC 和 LNU 显著缩短了术后住院时间(P =.003),术后 30 天内并发症发生率降低,但无统计学意义(P =.25)。两组在 6 个月内的病理特征和复发情况无显著差异。
我们的结果表明,与传统的开放性手术相比,整块同期 RARC 和 LNU 是更安全的手术方法,具有同等的短期肿瘤学结果。在机器人辅助肾输尿管切除术无法实施的国家,它可以成为一种标准的微创外科方法。